We are live on ! Find out more
AC

Apogem Capital Portfolio holdings

AUM $303K
1-Year Est. Return 46.01%
This Fund
S&P 500
This Quarter Est. Return
+7.76%
1 Year Est. Return
-46.01%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$152M
AUM Growth
-$4.75M
Cap. Flow
-$9.34M
Cap. Flow %
-6.13%
Top 10 Hldgs %
27.08%
Holding
220
New
35
Increased
52
Reduced
54
Closed
46

Top Buys

Rank Stock Value
1
TTSH
Tile Shop Holdings
TTSH
+$1.86M
2
TGLS icon
Tecnoglass
TGLS
+$1.3M
3
VRSK icon
Verisk Analytics
VRSK
+$938K
4
GPN icon
Global Payments
GPN
+$842K
5
BLZE icon
Backblaze
BLZE
+$763K

Top Sells

Rank Stock Value
1
BCS icon
Barclays
BCS
+$1.57M
2
SYNA icon
Synaptics
SYNA
+$1.45M
3
LYG icon
Lloyds Banking Group
LYG
+$1.04M
4
ASO icon
Academy Sports + Outdoors
ASO
+$966K
5
BXC icon
BlueLinx
BXC
+$855K

Sector Composition

Rank Sector Weight
1 Technology 26.32%
2 Industrials 17.64%
3 Consumer Discretionary 14.66%
4 Financials 10.09%
5 Healthcare 8.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PKE icon
151
Park Aerospace
PKE
$720M
$238K 0.16%
18,000
– –
TFII icon
152
TFI International
TFII
$11.6B
$233K 0.15%
2,076
-1,382
-40% -$150K
FBC
153
DELISTED
Flagstar Bancorp, Inc. New
FBC
$233K 0.15%
4,861
-755
-13% -$37.5K
VVNT
154
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
$224K 0.15%
+22,915
New +$225K
CZOO
155
DELISTED
Cazoo Group Ltd
CZOO
$218K 0.14%
+18
New +$278K
PRQR icon
156
ProQR Therapeutics
PRQR
$244M
$215K 0.14%
26,875
+5,045
+23% +$38.4K
RCKT icon
157
Rocket Pharmaceuticals
RCKT
$343M
$211K 0.14%
+9,666
New +$264K
PSTH
158
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
$207K 0.14%
10,484
– –
OPTU
159
Optimum Communications Inc
OPTU
$298M
$197K 0.13%
+12,157
New +$206K
PRTA icon
160
CALL
Prothena Corp
PRTA
$448M
$193K 0.13%
+3,900
New +$216K
STTK icon
161
Shattuck Labs
STTK
$646M
$166K 0.11%
19,545
+6,556
+50% +$90.3K
FARM
162
DELISTED
Farmer Brothers
FARM
$164K 0.11%
22,000
– –
BV icon
163
BrightView Holdings
BV
$1.24B
$155K 0.1%
11,000
-3,000
-21% -$45.1K
CGTX icon
164
Cognition Therapeutics
CGTX
$80.6M
$143K 0.09%
+22,691
New +$221K
PANA
165
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
$143K 0.09%
14,699
+131
+0.9% +$1.28K
SIOX
166
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$78K 0.05%
60,245
+20,803
+53% +$36.9K
ALIT icon
167
CALL
Alight
ALIT
$534M
$64K 0.04%
+295
New +$64K
CBAY
168
DELISTED
Cymabay Therapeutics
CBAY
$44K 0.03%
+12,924
New +$49.1K
ADEA icon
169
CALL
Adeia
ADEA
$2.55B
$40K 0.03%
7,938
– –
XCUR icon
170
Exicure
XCUR
$11M
$37K 0.02%
1,222
-1,406
-54% -$163K
ODT
171
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$31K 0.02%
+22,931
New +$54.2K
DRAYW
172
DELISTED
Macondray Capital Acquisition Corp. I Warrant
DRAYW
$10K 0.01%
+17,526
New +$10.9K
ABBV icon
173
AbbVie
ABBV
$465B
– –
-1,910
Closed -$206K
AMED
174
DELISTED
Amedisys
AMED
– –
-1,540
Closed -$230K
AROC icon
175
Archrock
AROC
$6.16B
– –
-41,437
Closed -$342K
5 6
7
8 9

Similar funds

IPCP
Iron Park Capital Partners New York $621K AUM 73.14% 1-Year Est. Return
EVCM
Emerging Variant Capital Management New York $905K AUM 22.98% 1-Year Est. Return
SHG
Sheares Healthcare Group Singapore $1.69M AUM 4.89% 1-Year Est. Return
EC
EMJ Capital Toronto, Ontario, Canada $3.12M AUM 40.6% 1-Year Est. Return
RIR
Rayliant Investment Research Santa Monica, California $6.94M AUM
FWM
Foresight Wealth Management Draper, Utah $6.98M AUM 13.2% 1-Year Est. Return
SKCP
Storm King Capital Partners New York $8.58M AUM 50.59% 1-Year Est. Return
OP
Osmium Partners Greenbrae, California $10.4M AUM 73.79% 1-Year Est. Return

Apogem Capital's Q4 2021 Portfolio in Review

As of Q4 2021, Apogem Capital held 220 positions worth $152M, down 3% from $157M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Apogem Capital withdrew a net $9.34M in Q4 2021, closing 46 positions and reducing 54 holdings. Its most notable exit was Synaptics, an estimated $1.45M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Apogem Capital opened a new position in Tecnoglass worth $1.21M.

  • Apogem Capital's largest Q4 2021 buy was Tecnoglass: 46,266 shares worth $1.21M.
  • Apogem Capital added most to Tile Shop Holdings in Q4 2021, an estimated $1.86M increase.
  • Apogem Capital's biggest Q4 2021 reduction was Barclays, cutting an estimated $1.57M.
  • Apogem Capital fully exited Synaptics in Q4 2021, selling an estimated $1.45M.
  • Apogem Capital's ten largest holdings make up 27% of its $152M portfolio in Q4 2021.
  • Apogem Capital opened 35 new positions and closed 46 in Q4 2021.
  • Apogem Capital's portfolio value fell 3% quarter-over-quarter to $152M.

Based on Apogem Capital's 13F filing for Q4 2021, filed 14 Feb 2022.